Literature DB >> 33654307

BRAF-mutant ctDNA predicts outcomes.

Peter Sidaway1.   

Abstract

Entities:  

Year:  2021        PMID： 33654307     DOI： 10.1038/s41571-021-00494-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study.

Authors:  Mahrukh M Syeda; Jennifer M Wiggins; Broderick C Corless; Georgina V Long; Keith T Flaherty; Dirk Schadendorf; Paul D Nathan; Caroline Robert; Antoni Ribas; Michael A Davies; Jean Jacques Grob; Eduard Gasal; Matthew Squires; Mahtab Marker; James Garrett; Jan C Brase; David Polsky
Journal:  Lancet Oncol       Date:  2021-02-12       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.